Home > Insider Trading > Filing (0001209191-14-027621)

Filing Details

Accession Number:: 0001209191-14-027621
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-04-15 17:45:01
Reporting Period:: 2014-04-15

Filing Date:: 2014-04-15
Accepted Time:: 2014-04-15 17:45:01
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1328143	Adamas Pharmaceuticals Inc	ADMS	Pharmaceutical Preparations (2834)	421560076

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1503381	W. William Ericson	C/O Mohr Davidow Ventures 3000 Sand Hill Road, #3-290 Menlo Park CA 94025		Yes	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2014-04-15	1,029,984	$0.00	3,772,686	No	4	C	Indirect	MDV VII LP, nom for MDV VII LP, MDV VII Leaders' Fund LP, MDV ENF VII (A) LP, and MDV ENF VII (B) LP
Common Stock	Acquisiton	2014-04-15	511,328	$0.00	511,328	No	4	C	Indirect	MDV IX, L.P., as nominee for MDV IX, L.P., and MDV ENF IX, L.P.
Common Stock	Acquisiton	2014-04-15	265,150	$16.00	265,150	No	4	P	Indirect	MDV VII, L.P.
Common Stock	Acquisiton	2014-04-15	6,043	$16.00	6,043	No	4	P	Indirect	MDV ENF VII (A), L.P.
Common Stock	Acquisiton	2014-04-15	3,146	$16.00	3,146	No	4	P	Indirect	MDV ENF VII (B), L.P.
Common Stock	Acquisiton	2014-04-15	25,661	$16.00	25,661	No	4	P	Indirect	MDV VII Leaders' Fund, L.P.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	MDV VII LP, nom for MDV VII LP, MDV VII Leaders' Fund LP, MDV ENF VII (A) LP, and MDV ENF VII (B) LP
No	4	C	Indirect	MDV IX, L.P., as nominee for MDV IX, L.P., and MDV ENF IX, L.P.
No	4	P	Indirect	MDV VII, L.P.
No	4	P	Indirect	MDV ENF VII (A), L.P.
No	4	P	Indirect	MDV ENF VII (B), L.P.
No	4	P	Indirect	MDV VII Leaders' Fund, L.P.

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series AA Convertible Preferred Stock	Disposition	2014-04-15	1,029,516	$0.00	1,029,516	$0.00
Common Stock	Series AA-1 Convertible Preferred Stock	Disposition	2014-04-15	468	$0.00	468	$0.00
Common Stock	Series AA Convertible Preferred Stock	Disposition	2014-04-15	511,328	$0.00	511,328	$0.00

Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Stock Option (Right to Buy)	$9.00		2024-02-02	30,000	30,000	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2024-02-02	30,000	30,000	Direct

Footnotes

Upon the closing of the Issuer's initial public offering, each share of Series AA Preferred Stock automatically converted into 1 share of Common Stock for no additional consideration and had no expiration date.
Upon the closing of the Issuer's initial public offering, each 1000 shares of Series AA-1 Preferred Stock automatically converted into 1 share of Common Stock for no additional consideration and had no expiration date.
Seventh MDV Partners, L.L.C. is the general partner of MDV VII, L.P., as nominee for MDV VII, L.P., MDV VII Leaders' Fund, L.P., MDV ENF VII(A), L.P, and MDV ENF(B), L.P. and has sole voting and investment power over the shares. William Ericson, a general partner with Mohr Davidow Ventures, may be deemed to indirectly beneficially own the shares affiliated with Mohr Davidow Ventures.
William Ericson is a Managing Member of Ninth MDV Partners, L.L.C., the general partner of MDV IX, L.P., as nominee for MDV IX, L.P., and MDV ENF IX, L.P. William Ericson may be deemed to share voting and dispositive power over the shares held by MDV IX, L.P., as nominee for MDV IX, L.P., and MDV ENF IX, L.P.
The shares do not have an expiration date.
The Option shares shall vest as follows: 1/3rd of the shares subject to such option shall vest each year after February 2, 2014, subject to Reporting Person's Continuous Service (as defined in the Issuer's 2007 Stock Plan) as of each such date. The Option shares are subject to an early exercise right and may be exercised in full prior to vesting.